BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12722342)

  • 1. [vWF-cleaving protease/ADAMTS 13].
    Matsumoto M; Yagi H; Fujimura Y
    Rinsho Ketsueki; 2003 Mar; 44(3):159-67. PubMed ID: 12722342
    [No Abstract]   [Full Text] [Related]  

  • 2. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
    Furlan M
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
    N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Sarkodee-Adoo C; Gojo I; Heyman MR
    N Engl J Med; 1999 Apr; 340(17):1368; author reply 1369. PubMed ID: 10223876
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombotic microangiopathies.
    Nzerue CM
    N Engl J Med; 2002 Dec; 347(26):2171-3; author reply 2171-3. PubMed ID: 12501234
    [No Abstract]   [Full Text] [Related]  

  • 6. Assays of von Willebrand factor-cleaving protease: a test for diagnosis of familial and acquired thrombotic thrombocytopenic purpura.
    Furlan M; Lämmle B
    Semin Thromb Hemost; 2002 Apr; 28(2):167-72. PubMed ID: 11992240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAMTS13, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome.
    George JN
    Curr Hematol Rep; 2005 May; 4(3):167-9. PubMed ID: 15865866
    [No Abstract]   [Full Text] [Related]  

  • 8. von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Remuzzi G; Galbusera M; Noris M; Canciani MT; Daina E; Bresin E; Contaretti S; Caprioli J; Gamba S; Ruggenenti P; Perico N; Mannucci PM;
    Blood; 2002 Aug; 100(3):778-85. PubMed ID: 12130486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic thrombocytopenic purpura attributable to von Willebrand factor-cleaving protease inhibitor in an 8-year-old boy.
    Robson WL; Tsai HM
    Pediatrics; 2002 Feb; 109(2):322-5. PubMed ID: 11826215
    [No Abstract]   [Full Text] [Related]  

  • 10. Von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome.
    Fujimura Y; Matsumoto M; Yagi H; Yoshioka A; Matsui T; Titani K
    Int J Hematol; 2002 Jan; 75(1):25-34. PubMed ID: 11843286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura].
    Masset C; Dubois B; Rorive G
    Rev Med Liege; 2002 Jan; 57(1):33-9. PubMed ID: 11899496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [TTP/HUS and VWF/ADAMTS-13].
    Fujimura Y
    Rinsho Ketsueki; 2003 Dec; 44(12):1144-53. PubMed ID: 14978930
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular mechanisms in thrombotic thrombocytopenic purpura.
    Tsai HM
    Semin Thromb Hemost; 2004 Oct; 30(5):549-57. PubMed ID: 15497097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic microangiopathies.
    Tarr PI; Tsai HM; Chandler WL
    N Engl J Med; 2002 Dec; 347(26):2171-3; author reply 2171-3. PubMed ID: 12501862
    [No Abstract]   [Full Text] [Related]  

  • 15. Inappropriate use of positive predictive value in describing the rapid collagen binding assay for von Willebrand factor cleaving protease.
    Knovich MA; Case D; Owen J
    Thromb Haemost; 2003 Apr; 89(4):768-9. PubMed ID: 12669136
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
    Shibagaki Y; Fujita T
    Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Not known from ADAM(TS-13)--novel insights into the pathophysiology of thrombotic microangiopathies.
    Wolf G
    Nephrol Dial Transplant; 2004 Jul; 19(7):1687-93. PubMed ID: 15128885
    [No Abstract]   [Full Text] [Related]  

  • 18. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
    Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
    Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Upshaw-Schulman syndrome congenital thrombotic thrombocytopenic purpura or hemolytic-uremic syndrome? Yes to both.
    Fujimura Y
    J Thromb Haemost; 2003 Nov; 1(11):2457-8. PubMed ID: 14629488
    [No Abstract]   [Full Text] [Related]  

  • 20. Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).
    Licht C; Stapenhorst L; Simon T; Budde U; Schneppenheim R; Hoppe B
    Kidney Int; 2004 Sep; 66(3):955-8. PubMed ID: 15327386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.